Skip to main content

Advertisement

Table 2 Number of patients for whom a VTE prophylaxis was prescribed by period of time

From: Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry

n (%) Abdominal (N = 435) Pelvic (N = 390) Abdominal + Pelvic (N = 96) Total (N = 921)
Period of intake
 Before surgery 1 (0.2) 4 (1.0) 0 5 (0.5)
 From surgery to hospital discharge 387 (89.0) 357 (91.5) 85 (88.5) 829 (90.0)
  None 48 (11.0) 33 (8.5) 11 (11.5) 92 (10.0)
  Mechanical only 10 (2.3) 18 (4.6) 0 28 (3.0)
  Pharmacological only 173 (39.8) 149 (38.2) 50 (52.1) 372 (40.4)
  Mechanical + Pharmacological 204 (46.9) 190 (48.7) 35 (36.5) 429 (46.6)
 After hospital discharge 104 (23.9) 126 (32.3) 31 (32.3) 261 (28.3)
  None 331 (76.1) 329 (67.7)   660 (71,7)
  Mechanical only 8 (1.8) 44 (9.1)   52 (5.6)
  Pharmacological only 90 (20.7) 105 (21.6)   195 (21.2)
  Mechanical + Pharmacological 6 (1.4) 8 (1.6)   14 (1.5)
 During the whole study (from surgery to post-hospital discharge) 387 (89.0) 360 (92.3) 85 (88.5) 832 (90.3)
  None 48 (11.0) 30 (7.7) 11 (11.5) 89 (9.7)
  Mechanical only 10 (2.3) 18 (4.6) 0 28 (3.0)
  Pharmacological only 173 (39.8) 152 (39.0) 50 (52.1) 375 (40.7)
  Mechanical + Pharmacological 204 (46.9) 190 (48.7) 35 (36.5) 429 (46.6)
  1. VTE venous thromboembolism